Galera Therapeutics, Inc. (GRTX)
USD 0.03
(-2.17%)
USD 0.03
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 259 Thousand | 114 Thousand | 778 Thousand | 368 Thousand | 267 Thousand | 127 Thousand |
| Gross Profit | -259 Thousand | -114 Thousand | -778 Thousand | -368 Thousand | -267 Thousand | -127 Thousand |
| Operating Expenses | 46.95 Million | 51.22 Million | 73.36 Million | 70.55 Million | 50.69 Million | 24.25 Million |
| Selling, General and Administrative Expenses | 22.83 Million | 20.21 Million | 20.95 Million | 15.7 Million | 8.35 Million | 5.59 Million |
| Research and Development Expenses | 24.11 Million | 31.01 Million | 52.41 Million | 54.84 Million | 42.33 Million | 18.66 Million |
| Other Expenses | - | -11.06 Million | -7.16 Million | -3.68 Million | -1.24 Million | - |
| Cost and Expenses | 46.95 Million | 51.22 Million | 73.36 Million | 70.55 Million | 50.69 Million | 24.25 Million |
| Operating Income | -46.95 Million | -51.22 Million | -73.36 Million | -70.55 Million | -50.69 Million | -24.25 Million |
| Interest Expense | - | 11.57 Million | 7.19 Million | 4.88 Million | 3.03 Million | 220 Thousand |
| Income Tax Expense | - | -70 Thousand | 7.19 Million | -16 Thousand | -9000.00 | -223 Thousand |
| Earnings before Tax | -59.08 Million | -62.29 Million | -80.53 Million | -74.23 Million | -51.93 Million | -23.89 Million |
| Net Income | -59.08 Million | -62.22 Million | -87.72 Million | -74.21 Million | -51.93 Million | -23.67 Million |
| Earnings Per Share Basic | -1.33 | -2.30 | -3.40 | -2.98 | -2.09 | -1.22 |
| Earnings Per Share Diluted | -1.33 | -2.30 | -3.40 | -2.98 | -2.09 | -1.22 |
| Weighted Average Shares Outstanding | 44.54 Million | 27.08 Million | 25.78 Million | 24.86 Million | 24.81 Million | 19.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.54 Million | 27.08 Million | 25.78 Million | 24.86 Million | 24.81 Million | 19.36 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -46.69 Million | -50.6 Million | -72.55 Million | -69.01 Million | -50.69 Million | -23.52 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 88 Thousand | - | - |
| Cost of Revenue | - | 9000.00 | 259 Thousand | 215 Thousand | 12 Thousand | 12 Thousand |
| Gross Profit | - | -9000.00 | -259 Thousand | -127 Thousand | -12 Thousand | -12 Thousand |
| Operating Expenses | 4.2 Million | 4.56 Million | 46.69 Million | 4.96 Million | 11.08 Million | 16.8 Million |
| Selling, General and Administrative Expenses | 2.77 Million | 3.08 Million | - | 1.77 Million | 4.99 Million | 9.24 Million |
| Research and Development Expenses | 1.43 Million | 1.48 Million | - | 3.18 Million | 6.09 Million | 7.56 Million |
| Other Expenses | - | - | - | 3.82 Million | - | - |
| Cost and Expenses | 4.2 Million | 4.57 Million | 46.95 Million | 5.17 Million | 11.08 Million | 16.8 Million |
| Operating Income | -4.2 Million | -4.57 Million | -46.95 Million | -5.17 Million | -13.39 Million | -16.8 Million |
| Interest Expense | - | - | -11.41 Million | 705 Thousand | 2.08 Million | 4.39 Million |
| Income Tax Expense | - | -34.27 Thousand | - | -10.63 Million | 2.08 Million | 494 Thousand |
| Earnings before Tax | -4.06 Million | -4.38 Million | -59.08 Million | -5.58 Million | -15.07 Million | -20.71 Million |
| Net Income | -4.06 Million | -4.38 Million | -59.08 Million | -5.58 Million | -15.07 Million | -20.71 Million |
| Earnings Per Share Basic | -0.07 | -0.08 | - | -0.10 | -0.33 | -0.48 |
| Earnings Per Share Diluted | -0.07 | -0.08 | - | -0.10 | -0.33 | -0.48 |
| Weighted Average Shares Outstanding | 54.39 Million | 54.39 Million | 44.54 Million | 54.38 Million | 45.47 Million | 42.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.39 Million | 54.39 Million | 44.54 Million | 54.38 Million | 45.47 Million | 42.91 Million |
| Gross Margin | - | - | - | -1.44 | - | - |
| EBIT Margin | - | - | - | -56.38 | - | - |
| Profit Margin | - | - | - | -63.49 | - | - |
| EBITDA | -4.05 Million | -4.56 Million | - | -4.96 Million | -10.66 Million | -16.3 Million |
| Earnings Before Tax Margin | - | - | - | -58.82 | - | - |
000637
SKLT
VINEETLAB
0355
RDOIF
FOM